Insider Stock Trading History of Shallcross Steven A


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Shallcross Steven A since year 2005. The trader's CIK number is 1263501. At the time of this reporting, Shallcross Steven A is the Chief Financial Officer of Cytomedix Inc . (stock ticker symbol CYME). See this page for all insider trading activities at Cytomedix Inc .

Note that in the past SHALLCROSS STEVEN A also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Shallcross Steven A since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2014-08-26 CMXI Cytomedix Inc Buy 27,500 .38 10,450
2014-08-20 CMXI Cytomedix Inc Buy 52,000 .39 20,280
2007-11-28 VNDA Vanda Pharmaceuticals Inc. Option Ex 3,300 2.78 9,174
2007-11-28 VNDA Vanda Pharmaceuticals Inc. Sale 3,300 9.00 29,700
2007-10-16 VNDA Vanda Pharmaceuticals Inc. Option Ex 3,300 2.78 9,174
2007-10-16 VNDA Vanda Pharmaceuticals Inc. Sale 3,300 17.93 59,169
2007-09-18 VNDA Vanda Pharmaceuticals Inc. Sale 3,300 14.81 48,873
2007-09-18 VNDA Vanda Pharmaceuticals Inc. Option Ex 3,300 2.78 9,174
2007-08-21 VNDA Vanda Pharmaceuticals Inc. Option Ex 3,300 2.78 9,174
2007-08-21 VNDA Vanda Pharmaceuticals Inc. Sale 3,300 15.21 50,193
2007-07-17 VNDA Vanda Pharmaceuticals Inc. Sale 3,300 20.63 68,079
2007-07-17 VNDA Vanda Pharmaceuticals Inc. Option Ex 3,300 .83 2,729
2007-06-19 VNDA Vanda Pharmaceuticals Inc. Sale 3,300 21.19 69,927
2007-06-19 VNDA Vanda Pharmaceuticals Inc. Option Ex 3,300 .83 2,729
2007-05-15 VNDA Vanda Pharmaceuticals Inc. Option Ex 3,300 .83 2,729
2007-05-15 VNDA Vanda Pharmaceuticals Inc. Sale 3,300 19.39 63,987
2007-04-17 VNDA Vanda Pharmaceuticals Inc. Option Ex 3,300 .83 2,729
2007-04-17 VNDA Vanda Pharmaceuticals Inc. Sale 3,300 21.58 71,214
2007-03-20 VNDA Vanda Pharmaceuticals Inc. Sale 3,300 23.08 76,164
2007-03-20 VNDA Vanda Pharmaceuticals Inc. Option Ex 3,300 .83 2,729
2007-01-16 VNDA Vanda Pharmaceuticals Inc. Option Ex 3,300 .83 2,729
2007-01-16 VNDA Vanda Pharmaceuticals Inc. Sale 3,200 25.41 81,302
2007-11-16 VNDA Vanda Pharmaceuticals Inc. Sale 100 25.60 2,560
2006-12-11 VNDA Vanda Pharmaceuticals Inc. Option Ex 10,000 .83 8,300
2006-12-11 VNDA Vanda Pharmaceuticals Inc. Sale 10,000 26.45 264,500

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Shallcross Steven A (Chief Financial Officer of Cytomedix Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.